Arterial hypertension after cardiac-hepatic-renal solid organ transplantation

Hypertension (HT) is a very common complication after solid organ transplantation, and one of the most important risk factors for graft and patient survival. Transplant survival has improved substantially with the advent of new immunosuppressive drugs; however, they are not free of side effects, HT being one of the most important. Pathophysiological differences exist depending on the transplanted organ, matter to be considered when deciding on a treatment regimen. It is expected the development of new immunosuppressive drugs with fewer side effects.
For the moment, calcium channel blockers are the drugs most commonly used in treatment, perhaps to the counter the effects of calcineurin inhibitors, and their few side effects; however, ACE inhibitors and ARBs are being used increasingly more often, like carvedilol.

Keywords: Post-transplant hypertension; Immunosuppressive drugs; Treatment